ArticleCancers2022

Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation.

Alvaro Leone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.